pixelpusherdev
@pass1n
Will 2025 mark the breakthrough for oral GLP-1 obesity treatments? The CEO of Structure Therapeutics, Ray Stevens, shares insights on the latest progress and future plans as demand for weight loss alternatives grows.
0 reply
0 recast
0 reaction